% alzhub.org library filter
% Source: https://alzhub.org/research?author=Mintzer+J&access=free&atag=randomized
% 6 entries, in the order the page lists them. Built from alzhub.org's own records.
% 0 entries have no readable author in the source record and carry no author field.

@article{turner2015-26362286,
  author  = {Turner, R. S. and Thomas, R. G. and Craft, S. and van Dyck, C. H. and Mintzer, J. and Reynolds, B. A. and Brewer, J. B. and Rissman, R. A. and others},
  title   = {{A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease}},
  journal = {Neurology},
  year    = {2015},
  doi     = {10.1212/wnl.0000000000002035},
  pmid    = {26362286},
  url     = {https://doi.org/10.1212/wnl.0000000000002035}
}

@article{mintzer2021-34570180,
  author  = {Mintzer, J. and Lanctôt, K. L. and Scherer, R. W. and Rosenberg, P. B. and Herrmann, N. and van Dyck, C. H. and Padala, P. R. and Brawman-Mintzer, O. and others},
  title   = {{Effect of Methylphenidate on Apathy in Patients With Alzheimer Disease: The ADMET 2 Randomized Clinical Trial}},
  journal = {JAMA neurology},
  year    = {2021},
  doi     = {10.1001/jamaneurol.2021.3356},
  pmid    = {34570180},
  url     = {https://doi.org/10.1001/jamaneurol.2021.3356}
}

@article{schneider2016-26771737,
  author  = {Schneider, L. S. and Frangakis, C. and Drye, L. T. and Devanand, D. P. and Marano, C. M. and Mintzer, J. and Mulsant, B. H. and Munro, C. A. and others},
  title   = {{Heterogeneity of Treatment Response to Citalopram for Patients With Alzheimer's Disease With Aggression or Agitation: The CitAD Randomized Clinical Trial}},
  journal = {The American journal of psychiatry},
  year    = {2016},
  doi     = {10.1176/appi.ajp.2015.15050648},
  pmid    = {26771737},
  url     = {https://doi.org/10.1176/appi.ajp.2015.15050648}
}

@article{devanand2012-21407047,
  author  = {Devanand, D. P. and Mintzer, J. and Schultz, S. and Sultzer, D. and de la Pena, D. and Gupta, S. and Colon, S. and Schimming, C. and others},
  title   = {{The antipsychotic discontinuation in Alzheimer disease trial: clinical rationale and study design}},
  journal = {The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry},
  year    = {2012},
  doi     = {10.1097/jgp.0b013e3182110563},
  pmid    = {21407047},
  url     = {https://doi.org/10.1097/jgp.0b013e3182110563}
}

@article{ruthirakuhan2026-42178577,
  author  = {Ruthirakuhan, M. and Mills, M. and Rosenberg, P. and Haughey, N. and Mintzer, J. and Brawman-Mintzer, O. and Craft, S. and Herrmann, N. and others},
  title   = {{Uncovering lipid biomarkers linked to methylphenidate efficacy in treating apathy in Alzheimer's disease: insights from the ADMET 2 trial}},
  journal = {Alzheimer's research \& therapy},
  year    = {2026},
  doi     = {10.1186/s13195-026-02055-y},
  pmid    = {42178577},
  url     = {https://doi.org/10.1186/s13195-026-02055-y}
}

@article{peters2011-22228829,
  author  = {Peters, M. E. and Vaidya, V. and Drye, L. T. and Rosenberg, P. B. and Martin, B. K. and Porsteinsson, A. P. and Frangakis, C. E. and Mintzer, J. and others},
  title   = {{Sertraline for the treatment of depression in Alzheimer disease: genetic influences}},
  journal = {Journal of geriatric psychiatry and neurology},
  year    = {2011},
  doi     = {10.1177/0891988711422527},
  pmid    = {22228829},
  url     = {https://doi.org/10.1177/0891988711422527}
}